- Home
- Labeler Index
- Celltrion Usa, Inc.
- 72606-022
- NDC Crossover: 72606-022 Adalimumab
NDC Crossover 72606-022 Adalimumab
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Adalimumab
Explore similar products and medications to NDC 72606-022 Adalimumab a human prescription drug with other products crossover matching the same product name (Adalimumab) or generic name (Adalimumab-aaty), and the same administration route (subcutaneous) or dosage form (injection). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 72606-023 | Yuflyma | Adalimumab | Injection | Subcutaneous | Celltrion Usa, Inc. | Human Prescription Drug |
| 72606-024 | Yuflyma | Adalimumab | Injection | Subcutaneous | Celltrion Usa, Inc. | Human Prescription Drug |
| 72606-030 | Yuflyma | Adalimumab | Injection | Subcutaneous | Celltrion Usa, Inc. | Human Prescription Drug |
| 72606-040 | Adalimumab | Adalimumab-aaty | Injection | Subcutaneous | Celltrion Usa, Inc. | Human Prescription Drug |
| 72606-041 | Adalimumab | Adalimumab-aaty | Injection | Subcutaneous | Celltrion Usa, Inc. | Human Prescription Drug |